Dia Spectr
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lustman, P. J.
Right arrow Articles by Clouse, R. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lustman, P. J.
Right arrow Articles by Clouse, R. E.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Spectrum 17:147, 2004
© American Diabetes Association ®, Inc., 2004

Depression: A Potentially Modifiable Risk Factor for Diabetes and Its Complications

Patrick J. Lustman, PhD, Guest Editor and Ray E. Clouse, MD, Guest Editor

In Brief The epidemic rise in diabetes in the United States has prompted scientists to expand the search for modifiable risk factors, for both the disease itself and associated morbidity. In this From Research to Practice section, the authors review mounting evidence pointing toward depression as a medical risk factor for the development of type 2 diabetes and for progression of complications from either type 1 or type 2 diabetes. They offer practical advice for the management of depression in patients with diabetes, including 1) how to identify people in need of help, 2) how to get people to accept the help they need, and 3) what to expect from treatment options in the practice setting.


   Footnotes
 
Note of disclosure: The authors receive research support from GlaxoSmithKline, makers of pharmaceutical products for the treatment of depression and diabetes.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 The Diabetes EducatorHome page
AADE Position Statement: Individualization of Diabetes Self-management Education
The Diabetes Educator, January 1, 2007; 33(1): 45 - 49.
[Full Text] [PDF]

Home page
 Clin. DiabetesHome page
M. M. Williams, R. E. Clouse, and P. J. Lustman
Treating Depression to Prevent Diabetes and Its Complications: Understanding Depression as a Medical Risk Factor
Clin. Diabetes, April 1, 2006; 24(2): 79 - 86.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lustman, P. J.
Right arrow Articles by Clouse, R. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lustman, P. J.
Right arrow Articles by Clouse, R. E.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum